Literatur
Navari RI et al (2012) The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy. J Clin Oncol 30(Suppl):Abstr. 9064
Ryan JL et al (2012) Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 20(7):1479–1489
Parker C et al (2013) Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 369(3):213–223
Rick O et al (2012) Reintegrating cancer patients into the workplace. Dtsch Arztebl Int 109(42):702–708
Link H et al (2013) How oncologists adhere to evidence-based G-CSF-guidelines to prevent febrile neutropenia: a sample survey in hospitals and practices in Germany. J Clin Oncol 31(Suppl):Abstr. 6591
Stiel S et al (2010) Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care: the German version of the edmonton symptom assessment scale (ESAS). Schmerz 24(6):596–604
Stewart-Knight K et al (2012) Does the distress thermometer work? A systematic review of the evidence for its use and validity. BMJ Support Palliat Care 2(Suppl 1)A30:Poster 44
Gaertner J et al (2012) Recommending early integration of palliative care – does it work? Support Care Cancer 20(3):507–513
Einhaltung ethischer Richtlinien
Interessenkonflikt. D. Berger gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dieser Bericht wurde erstellt auf der Grundlage verschiedener Vorträge im Rahmen des Deutschen Krebskongresses 2014 aus dem Schwerpunkt „Supportivtherapie und Palliativmedizin“.
Rights and permissions
About this article
Cite this article
Berger, D. Mehr vom Deutschen Krebskongress 2014. Onkologe 20, 772–775 (2014). https://doi.org/10.1007/s00761-014-2747-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-014-2747-6